Mirdametinib 1 mg, 2mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 1 mg, 2mg
Reference Brands: Gomekli (USA), Ezmekly (EU/UK)
Category: Oncology Cancer Care
Mirdametinib is an orally administered small-molecule inhibitor of MEK1 and MEK2 (part of the RAS/RAF/MEK/ERK signalling pathway). It is indicated for the treatment of patients (2 years and older) with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that cannot be completely removed by surgery.
Mirdametinib — third party manufacturing & bulk supply
Mirdametinib 1 mg, 2mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Mirdametinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Mirdametinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mirdametinib is used for the treatment of adults and children aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. It helps shrink tumor size and relieve symptoms such as pain and functional impairment.
Mirdametinib is made from the active compound mirdametinib, a synthetic small-molecule inhibitor of MEK1 and MEK2 enzymes, which are part of the MAPK signaling pathway involved in cell growth and differentiation.
The trade name of Mirdametinib is Gomekli.
Mirdametinib is manufactured by SpringWorks Therapeutics, Inc.
The generic name of this product is Mirdametinib.
The brand name is Gomekli.
Mirdametinib is manufactured in the United States by SpringWorks Therapeutics under approved regulatory standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
